0001689548-21-000011.txt : 20210217
0001689548-21-000011.hdr.sgml : 20210217
20210217165643
ACCESSION NUMBER: 0001689548-21-000011
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210212
FILED AS OF DATE: 20210217
DATE AS OF CHANGE: 20210217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mastrocola Lauren
CENTRAL INDEX KEY: 0001827639
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39620
FILM NUMBER: 21645741
MAIL ADDRESS:
STREET 1: C/O PRAXIS PRECISION MEDICINES, INC.
STREET 2: ONE BROADWAY, 16TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Praxis Precision Medicines, Inc.
CENTRAL INDEX KEY: 0001689548
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE BROADWAY
STREET 2: 16TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-949-2220
MAIL ADDRESS:
STREET 1: ONE BROADWAY
STREET 2: 16TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
wf-form4_161359894605862.xml
FORM 4
X0306
4
2021-02-12
0
0001689548
Praxis Precision Medicines, Inc.
PRAX
0001827639
Mastrocola Lauren
C/O PRAXIS PRECISION MEDICINES, INC.
ONE BROADWAY, 16TH FLOOR
CAMBRIDGE
MA
02142
0
1
0
0
Principal Accounting Officer
Common Stock
2021-02-12
4
A
0
8200
0
A
20418
D
Stock Option (Right to Buy)
52.53
2021-02-12
4
A
0
48700
0
A
2031-02-12
Common Stock
48700.0
48700
D
Ms. Mastrocola was awarded 8,200 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on the one-year anniversary of the vesting commencement date of February 12, 2021. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
The shares underlying this stock option vest over a four-year period, with 27,175 shares vesting on the one-year anniversary of the vesting commencement date of February 12, 2021 and the remaining 21,525 shares vesting in 36 equal monthly installments following such first anniversary, subject to the reporting person's continued service through each vesting date.
/s/ Alex Nemiroff, as Attorney-in-Fact
2021-02-17